Skip to main content
. 2019 Aug 28;93(18):e00579-19. doi: 10.1128/JVI.00579-19

TABLE 2.

Parameter estimation

Parameter Mean 95% confidence interval
Antibody half-life (days), log2Ab 24 22, 26
Long-lived cell half-life (yrs), log2L 6.0 2.7, 13
Short-lived cell half-life (days), log2S
    MVA/Ad26 D29 group 2.0 1.3, 3.0
    MVA/Ad26 D57 group 4.9 3.1, 7.7
    Ad26/MVA D27 group 1.2 0.8, 1.9
    Ad26/MVA D57 group 3.0 1.9, 4.7
ϕS (ELISA units/ml days−1) 2,755 1,852, 4,100
ϕL (ELISA units/ml days−1)
    East African participants 16.6 13.7, 20.1
    European participants 70.7 54.0, 92.7
σϕS (interindividual SD on ϕS) 0.92 0.83, 1.01
σϕL (interindividual SD on ϕL) 0.85 0.78, 0.92
σδAb (interindividual SD on δAb) 0.30 0.24, 0.36
σAb (SD on observations) 0.10 0.10, 0.10